Intragastric Balloon Treatment Enhances Weight Maintenance Adjunct to Low-Energy Diet and Group-Based Cognitive Behavioural Therapy: A Randomized Controlled Trial Visa övriga samt affilieringar
2026 (Engelska) Ingår i: Diabetes, obesity and metabolism, ISSN 1462-8902, E-ISSN 1463-1326, Vol. 28, nr 8, s. 7300-7311Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
AIMS: Low-energy diet (LED) plus cognitive-behavioural therapy (CBT) produces substantial short-term weight loss in obesity, but long-term maintenance remains difficult. We evaluated whether adding intragastric balloon (IGB) treatment to group-based CBT improves weight maintenance after initial weight loss using LED.
MATERIALS AND METHODS: In this open-label randomized controlled trial, adults aged 30-65 years with BMI 32.5-45 kg/m2 underwent a 6-month run-in period combining LED and group-based CBT and were subsequently randomized to CBT and 1-year IGB or CBT alone. The primary endpoint was weight change in percent between randomization (6 months from enrollment) and 18 months (from enrollment), compared to total body weight (TBW) at enrollment. Secondary outcomes included the proportion of participants achieving weight loss thresholds, metabolic parameters and health-related quality of life (HRQoL).
RESULTS: Of 126 enrolled (mean 43.7 years; BMI 38.0 kg/m2), 107 were randomized 6 months after enrollment (IGB n = 51; CBT n = 56) and lost -18.7% (SE: 0.64) of TBW. At 18 months, the mean weight change from randomization was 5.2% with IGB versus 10.1% with CBT (p < 0.001). A significantly greater proportion of IGB recipients achieved ≥ 5% (84.3% vs. 63.6%; p = 0.021) and ≥ 10% (70.6% vs. 45.5%; p = 0.013) weight loss after 18 months, compared to the CBT group. Improvements in metabolic parameters and HRQoL showed no between-group differences.
CONCLUSIONS: As an adjunct to group-based CBT and after LED-induced weight loss, IGB treatment provided a modest advantage in weight maintenance for up to 18 months, although safety concerns remain and long-term studies are warranted.
Ort, förlag, år, upplaga, sidor Wiley-Blackwell Publishing Inc., 2026. Vol. 28, nr 8, s. 7300-7311
Nyckelord [en]
efficacy, health‐related quality of life, obesity treatment, randomized controlled trial, safety
Nationell ämneskategori
Näringslära och dietkunskap Folkhälsovetenskap, global hälsa och socialmedicin
Identifikatorer URN: urn:nbn:se:oru:diva-129180 DOI: 10.1111/dom.70865 ISI: 001783790400001 PubMedID: 42236302 OAI: oai:DiVA.org:oru-129180 DiVA, id: diva2:2065972
Forskningsfinansiär Region Örebro län, OLL-886441 Region Örebro län, OLL-935216 Region Örebro län, OLL-939125 Region Örebro län, OLL-964732 Region Örebro län, OLL-970429 Region Örebro län, OLL-983440 Nyckelfonden, OLL-886841 Nyckelfonden, OLL-935201 Nyckelfonden, OLL-973006
Anmärkning Funding Agencies:
This work was supported by the Region Örebro län (OLL-886441, OLL-935216, OLL-939125, OLL-964732 , OLL-970429, OLL-983440), Nyckelfonden (OLL-886841, OLL-935201, OLL-973006), Apollo Endosurgery Inc.
2026-06-042026-06-042026-07-08 Bibliografiskt granskad